TY - JOUR
T1 - Addressing global disparities in blood pressure control
T2 - perspectives of the International Society of Hypertension
AU - Schutte, Aletta E.
AU - Jafar, Tazeen H.
AU - Poulter, Neil R.
AU - Damasceno, Albertino
AU - Khan, Nadia A.
AU - Nilsson, Peter M.
AU - Alsaid, Jafar
AU - Neupane, Dinesh
AU - Kario, Kazuomi
AU - Beheiry, Hind
AU - Brouwers, Sofie
AU - Burger, Dylan
AU - Charchar, Fadi J.
AU - Cho, Myeong Chan
AU - Guzik, Tomasz J.
AU - Al-Saedi, Ghazi F. Haji
AU - Ishaq, Muhammad
AU - Itoh, Hiroshi
AU - Jones, Erika S. W.
AU - Khan, Taskeen
AU - Kokubo, Yoshihiro
AU - Kotruchin, Praew
AU - Muxfeldt, Elizabeth
AU - Odili, Augustine
AU - Patil, Mansi
AU - Ralapanawa, Udaya
AU - Romero, Cesar A.
AU - Schlaich, Markus P.
AU - Shehab, Abdulla
AU - Mooi, Ching Siew
AU - Steckelings, U. Muscha
AU - Stergiou, George
AU - Touyz, Rhian M.
AU - Unger, Thomas
AU - Wainford, Richard D.
AU - Wang, Ji-Guang
AU - Williams, Bryan
AU - Wynne, Brandi M.
AU - Tomaszewski, Maciej
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Raised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific. We report that most countries failed to show sufficient improvements in BP control rates over the past three decades, with greater improvements mainly seen in some high-income countries, also reflected in substantial reductions in the burden of cardiovascular disease and deaths. Globally, there are significant inequities and disparities based on resources, sociodemographic environment, and race with subsequent disproportionate hypertension-related outcomes. Additional unique challenges in specific regions include conflict, wars, migration, unemployment, rapid urbanization, extremely limited funding, pollution, COVID-19-related restrictions and inequalities, obesity, and excessive salt and alcohol intake. Immediate action is needed to address suboptimal hypertension care and related disparities on a global scale. We propose a Global Hypertension Care Taskforce including multiple stakeholders and societies to identify and implement actions in reducing inequities, addressing social, commercial, and environmental determinants, and strengthening health systems implement a well-designed customized quality-of-care improvement framework.
AB - Raised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific. We report that most countries failed to show sufficient improvements in BP control rates over the past three decades, with greater improvements mainly seen in some high-income countries, also reflected in substantial reductions in the burden of cardiovascular disease and deaths. Globally, there are significant inequities and disparities based on resources, sociodemographic environment, and race with subsequent disproportionate hypertension-related outcomes. Additional unique challenges in specific regions include conflict, wars, migration, unemployment, rapid urbanization, extremely limited funding, pollution, COVID-19-related restrictions and inequalities, obesity, and excessive salt and alcohol intake. Immediate action is needed to address suboptimal hypertension care and related disparities on a global scale. We propose a Global Hypertension Care Taskforce including multiple stakeholders and societies to identify and implement actions in reducing inequities, addressing social, commercial, and environmental determinants, and strengthening health systems implement a well-designed customized quality-of-care improvement framework.
KW - Epidemiology
KW - Hypertension
KW - Global
KW - International
KW - Cardiovascular disease
KW - Regions
KW - Inequity
KW - Prevention
KW - Awareness
KW - Treatment
KW - Control
KW - JOINT NATIONAL COMMITTEE
KW - SUB-SAHARAN AFRICA
KW - RISK-FACTORS
KW - CARDIOVASCULAR EVENTS
KW - IMPLEMENTATION STRATEGIES
KW - NOCTURNAL HYPERTENSION
KW - SCIENTIFIC STATEMENT
KW - SOCIOECONOMIC-STATUS
KW - TREAT HYPERTENSION
KW - COST-EFFECTIVENESS
UR - http://www.scopus.com/inward/record.url?scp=85151574220&partnerID=8YFLogxK
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000865988700001
U2 - 10.1093/cvr/cvac130
DO - 10.1093/cvr/cvac130
M3 - Review article
C2 - 36219457
SN - 0008-6363
VL - 119
SP - 381
EP - 409
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 2
ER -